Identification of SLC41A3 as a novel player in magnesium homeostasis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  De Baaij, Jeroen H F ^a   Arjona, Francisco J ^a   Van Den Brand, Michiel ^a   Lavrijsen, Marla ^a   Lameris, Anke L L ^a   Bindels, René J M ^a   Hoenderop, Joost G J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CATION TRANSPORT PROTEIN; MAGNESIUM;

ANIMAL; BLOOD; GENETICS; HOMEOSTASIS; HYPERCALCIURIA; KIDNEY CALCIFICATION; KIDNEY TUBULE DISORDER; KNOCKOUT MOUSE; METABOLISM; MOUSE; PHYSIOLOGY; URINE;

ANIMALS; CATION TRANSPORT PROTEINS; HOMEOSTASIS; HYPERCALCIURIA; MAGNESIUM; MICE; MICE, KNOCKOUT; NEPHROCALCINOSIS; RENAL TUBULAR TRANSPORT, INBORN ERRORS;

EID: 84976566964     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep28565     Document Type: Article

References (40)

1. de Baaij, J. H. F., Hoenderop, J. G. J. & Bindels, R. J. M. Magnesium in Man: Implications for Health and Disease. Physiological Reviews 95, 1-46, doi: 10.1152/physrev.00012.2014 (2015).
2. Voets, T. et al. TRPM6 forms the Mg2+ influx channel involved in intestinal and renal Mg2+ absorption. The Journal of biological chemistry 279, 19-25, doi: 10.1074/jbc.M311201200 (2004).
3. Lameris, A. L., Monnens, L. A., Bindels, R. J. & Hoenderop, J. G. Drug-induced alterations in Mg2+ homoeostasis. Clinical science (London, England: 1979) 123, 1-14, doi: 10.1042/CS20120045 (2012).
4. de Baaij, J. H. et al. Elucidation of the distal convoluted tubule transcriptome identifies new candidate genes involved in renal Mg(2+ ) handling. American journal of physiology. Renal physiology 305, F1563-1573, doi: 10.1152/ajprenal.00322.2013 (2013).
5. Quamme, G. A. Molecular identification of ancient and modern mammalian magnesium transporters. American journal of physiology. Cell physiology 298, C407-429, doi: 10.1152/ajpcell.00124.2009 (2010).
6. Kolisek, M. et al. SLC41A1 is a novel mammalian Mg2+ carrier. The Journal of biological chemistry 283, 16235-16247, doi: 10.1074/jbc.M707276200 (2008).
7. Kolisek, M., Nestler, A., Vormann, J. & Schweigel-Rontgen, M. Human gene SLC41A1 encodes for the Na+ /Mg(2)+ exchanger. American journal of physiology. Cell physiology 302, C318-326, doi: 10.1152/ajpcell.00289.2011 (2012).
8. Mandt, T., Song, Y., Scharenberg, A. M. & Sahni, J. SLC41A1 Mg(2+ ) transport is regulated via Mg(2+ )-dependent endosomal recycling through its N-Terminal cytoplasmic domain. The Biochemical journal 439, 129-139, doi: 10.1042/BJ20110807 (2011).
9. Sponder, G., Rutschmann, K. & Kolisek, M. "Inside-in" or "inside-out"? The membrane topology of SLC41A1. Magnesium research: official organ of the International Society for the Development of Research on Magnesium 26, 176-181, doi: 10.1684/mrh.2014.0351 (2013).
10. Goytain, A. & Quamme, G. A. Functional characterization of human SLC41A1, a Mg2+ transporter with similarity to prokaryotic MgtE Mg2+ transporters. Physiological genomics 21, 337-342, doi: 10.1152/physiolgenomics.00261.2004 (2005).
11. Hattori, M., Tanaka, Y., Fukai, S., Ishitani, R. & Nureki, O. Crystal structure of the MgtE Mg2+ transporter. Nature 448, 1072-1075, doi: 10.1038/nature06093 (2007).
12. Wabakken, T., Rian, E., Kveine, M. & Aasheim, H. C. The human solute carrier SLC41A1 belongs to a novel eukaryotic subfamily with homology to prokaryotic MgtE Mg2+ transporters. Biochemical and biophysical research communications 306, 718-724 (2003).
13. Kolisek, M. et al. Substitution p.A350V in Na(+ )/Mg(2)(+ ) exchanger SLC41A1, potentially associated with Parkinson's disease, is a gain-of-function mutation. PloS one 8, e71096, doi: 10.1371/journal.pone.0071096 (2013).
14. Hurd, T. W. et al. Mutation of the Mg2+ transporter SLC41A1 results in a nephronophthisis-like phenotype. Journal of the American Society of Nephrology : JASN 24, 967-977, doi: 10.1681/ASN.2012101034 (2013).
15. Blake, J. A. et al. The Mouse Genome Database: integration of and access to knowledge about the laboratory mouse. Nucleic acids research 42, D810-817, doi: 10.1093/nar/gkt1225 (2014).
16. Satake, W. et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nature genetics 41, 1303-1307, doi: 10.1038/ng.485 (2009).
17. Yan, Y. et al. Genetic variants in the RAB7L1 and SLC41A1 genes of the PARK16 locus in Chinese Parkinson's disease patients. The International journal of neuroscience 121, 632-636, doi: 10.3109/00207454.2011.598983 (2011).
18. Lameris, A. L. et al. Segmental transport of Ca(2)(+ ) and Mg(2)(+ ) along the gastrointestinal tract. American journal of physiology. Gastrointestinal and liver physiology 308, G206-216, doi: 10.1152/ajpgi.00093.2014 (2015).
19. de Baaij, J. H. et al. Recurrent FXYD2 p.Gly41Arg mutation in patients with isolated dominant hypomagnesaemia. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association, doi: 10.1093/ndt/gfv014 (2015).
20. Schlingmann, K. P. et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nature genetics 31, 166-170, doi: 10.1038/ng889 (2002).
21. Walder, R. Y. et al. Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nature genetics 31, 171-174, doi: 10.1038/ng901 (2002).
22. Groenestege, W. M., Hoenderop, J. G., van den Heuvel, L., Knoers, N. & Bindels, R. J. The epithelial Mg2+ channel transient receptor potential melastatin 6 is regulated by dietary Mg2+ content and estrogens. Journal of the American Society of Nephrology: JASN 17, 1035-1043, doi: 10.1681/ASN.2005070700 (2006).
23. Blanchard, M. G. et al. Flavaglines Stimulate Transient Receptor Potential Melastatin Type 6 (TRPM6) Channel Activity. PloS one 10, e0119028, doi: 10.1371/journal.pone.0119028 (2015).
24. de Baaij, J. H. et al. P2X4 receptor regulation of transient receptor potential melastatin type 6 (TRPM6) Mg2+ channels. Pflugers Archiv: European journal of physiology 466, 1941-1952, doi: 10.1007/s00424-014-1440-3 (2014).
25. Nair, A. V. et al. Loss of insulin-induced activation of TRPM6 magnesium channels results in impaired glucose tolerance during pregnancy. Proceedings of the National Academy of Sciences of the United States of America 109, 11324-11329, doi: 10.1073/pnas.1113811109 (2012).
26. Thebault, S., Alexander, R. T., Tiel Groenestege, W. M., Hoenderop, J. G. & Bindels, R. J. EGF increases TRPM6 activity and surface expression. Journal of the American Society of Nephrology: JASN 20, 78-85, doi: 10.1681/ASN.2008030327 (2009).
27. Runnels, L. W., Yue, L. & Clapham, D. E. TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science 291, 1043-1047, doi: 10.1126/science.1058519 (2001).
28. Schmitz, C. et al. Regulation of vertebrate cellular Mg2+ homeostasis by TRPM7. Cell 114, 191-200 (2003).
29. Sahni, J. & Scharenberg, A. M. The SLC41 family of MgtE-like magnesium transporters. Molecular aspects of medicine 34, 620-628, doi: 10.1016/j.mam.2012.05.012 (2013).
30. Bisceglia, M., Galliani, C. A., Senger, C., Stallone, C. & Sessa, A. Renal cystic diseases: A review. Advances in anatomic pathology 13, 26-56, doi: 10.1097/01.pap.0000201831.77472.d3 (2006).
31. Meyerholz, D. K. & Hostetter, S. J. Unilateral perinephric pseudocyst secondary to hydronephrosis in a C57BL/6J mouse. Veterinary pathology 42, 496-498, doi: 10.1354/vp.42-4-496 (2005).
32. Meyers, M. A. Uriniferous perirenal pseudocyst: new observations. Radiology 117, 539-545, doi: 10.1148/117.3.539 (1975).
33. Chew, D. J., DiBartola, S. P. & Schenck, P. Canine and Feline Nephrology and Urology. (Elsevier Health Sciences, 2010).
34. Wein, A. J., Kavoussi, L. R. & Campbell, M. F. Campbell-Walsh urology/editor-in-chief, Alan J. Wein; [editors, Louis R. Kavoussi et al.]. (Elsevier Saunders, 2012).
35. Gyawali, P. R., Joshi, B. R. & Gurung, C. K. Correlation of calcium, phosphorus, uric acid and magnesium level in serum and 24 hours urine of patients with urolithiasis. Kathmandu University medical journal 9, 54-56 (2011).
36. Kato, Y. et al. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis. Urology 63, 7-11; discussion 11-12 (2004).
37. Su, C. J., Shevock, P. N., Khan, S. R. & Hackett, R. L. Effect of magnesium on calcium oxalate urolithiasis. The Journal of urology 145, 1092-1095 (1991).
38. Lin, E. P., Bhatt, S., Dogra, V. S. & Rubens, D. J. Sonography of Urolithiasis and Hydronephrosis. Ultrasound Clinics 2, 1-16, doi: 10.1016/j.cult.2007.01.007.
39. Markadieu, N. et al. A primary culture of distal convoluted tubules expressing functional thiazide-sensitive NaCl transport. American journal of physiology. Renal physiology 303, F886-892, doi: 10.1152/ajprenal.00114.2012 (2012).
40. Cui, X., Zhou, J., Qiu, J., Johnson, M. R. & Mrug, M. Validation of endogenous internal real-Time PCR controls in renal tissues. American journal of nephrology 30, 413-417, doi: 10.1159/000235993 (2009).